重庆医学Issue(27)：3262-3263,2.DOI:10.3969/j.issn.1671-8348.2013.27.022
依达拉奉联合纤溶酶治疗急性脑梗死的疗效观察
Effective observation on edaravone combined with fibrinolysin for treating acute cerebral infarction
熊联强 1钟华 1陈莉 1李颖 1汪顺利 1伍绍强1
作者信息
- 1. 重庆市南川区人民医院神经内科 408400
- 折叠
摘要
Abstract
Objective To observe the clinical effect of edaravone combined with fibrinolysin for treating acute cerebral infarc-tion .Methods 80 cases of acute cerebral infarction were randomly divided into the two groups .The treatment group(40 cases) was treated by edaravone injection 30mg plus normal saline 100 mL by intravenous drip ,twice daily ,fibrinolysin injection 100 U plus 5%glucose injection 250 mL by intravenous drip on 1 d ,subsequently 200U plus 5% glucose 250 mL by intravenous drip from the next day ,for 14 d;the control group(40 cases ) used fibrinolysin alone ,the dose and usage were same to the treatment group .The neuro-logical impairment scale scores(NIHSS) were monitored before and after treatment in the two groups .Results The NIHSS scores and Barthel index on 7 ,14 ,30 ,90 d after treatment in the treatment group were superior to those in the control group (P<0 .05) ,no statistical difference before treatment between the two group existed .Conclusion Edaravone combined with fibrinolysin has better effect for treating acute cerebral infarction .关键词
脑梗死/依达拉奉/纤溶酶Key words
braini nfarction/edaravone/fibrinogenase引用本文复制引用
熊联强,钟华,陈莉,李颖,汪顺利,伍绍强..依达拉奉联合纤溶酶治疗急性脑梗死的疗效观察[J].重庆医学,2013,(27):3262-3263,2.
